Cytokinetics (CYTK) Earnings Date & Reports

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CYTK is expected to report earnings to fall 3.33% to -145 cents per share on October 29

Cytokinetics CYTK Stock Earnings Reports

Q3'26

Est.

$-1.45

Q2'26

Beat

by $0.13

Q1'26

Missed

by $0.02

Q4'25

Beat

by $0.06

Q3'25

Missed

by $0.98

The last earnings report on August 06 showed earnings per share of -150 cents, beating the estimate of -162 cents. With 133.24K shares outstanding, the current market capitalization sits at 9.93B.

View a ticker or compare two or three

CYTK

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days